Jul 30, 2019
2019 got off to a fast start for oncology drug discovery, with numerous mergers, acquisitions and collaborations announced in quick succession.
These ventures provide a window into key trends in oncology research, where investigators are likely to focus their efforts, and the tools and technologies that will enable pharmaceutical and biotechnology companies to turn promise into efficacious therapies.
While the pace of innovation is accelerating, the challenges of increasing competition, pricing pressures and regulatory complexity are squeezing ROI.
In this environment, collaborative efforts will play a pivotal role in advancing oncology drug discovery effectively and efficiently.
Original article by Dr Michael Seiler
If you'd like to view the original article then follow the link below:
You can also download the original article pdf here:
For more information on Drug Discovery World, head to: